Menopause causes significant hormonal shifts that lead to increased visceral fat, insulin resistance, and higher blood pressure in women [1, 2].

These changes are critical because they impact long-term cardiovascular health and metabolic stability. The transition period alters how the female body processes energy and maintains vascular health, increasing the risk of chronic conditions.

Cardiologist Salete Nacif and presenter Roberto Kalil said the decline in estrogen during menopause triggers these metabolic and vascular shifts [1, 2]. This hormonal drop does not only affect reproductive health but extends to the entire body, manifesting as weight gain and an increase in visceral fat [1, 2, 3].

Beyond metabolic changes, the transition often involves the development of insulin resistance [1, 2]. This shift in how the body handles glucose can complicate blood sugar management and contribute to further weight gain [1, 2, 3].

Physical symptoms also impact daily quality of life. Experts said that hot flashes are common during this period, which often disturb sleep patterns [1, 2]. These sleep disturbances can create a cycle that further exacerbates metabolic stress and fatigue [1, 2].

The combination of higher blood pressure and increased visceral fat represents a shift in the body's baseline health markers [1, 2]. Because estrogen previously provided a protective effect on the vascular system, its absence leaves women more susceptible to cardiovascular fluctuations [1, 2].

Medical professionals said that understanding these changes is the first step in managing the transition. By identifying the link between hormonal decline and vascular health, women and providers can better address the risks associated with menopause [1, 2].

Menopause can lead to increased visceral fat, insulin resistance, and higher blood pressure.

The transition into menopause is not merely a reproductive milestone but a systemic health event. The loss of estrogen's protective effects on the heart and metabolism necessitates a shift in preventative care, focusing on cardiovascular monitoring and metabolic health to mitigate the increased risks of hypertension and insulin resistance.